Long-term safety and efficacy of memantine treatment in moderate to severe Alzheimer's disease: Results from a three-year trial

被引：0
|
作者：
Aupperle, P. M. [1 ]
Tariot, P. N. [2 ,3 ]
Safirstein, B.
Graham, S. M. [4 ]
Lee, G. [4 ]
Tocco, M. [4 ]
机构：
[1] Univ Med & Dent New Jersey, Piscataway, NJ 08854 USA
[2] Banner Alzheimer Inst, Phoenix, AZ USA
[3] MD Clin Trials Fdn Inc, Hollandale, FL USA
[4] Forest Res Inst, Jersey, NJ USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2007年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：54 / 54
页数：1
相关论文
共 50 条
  • [1] Long-term safety and efficacy of memantine treatment in moderate to severe Alzheimer's disease: Results from a three-year trial
    Tariot, Pierre
    Aupperle, Peter
    Safirstein, Beth
    Graham, Stephen
    Lee, Grace
    Tocco, Michael
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S198 - S198
  • [2] Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer's disease
    Puangthong, Umamon
    Hsiung, Ging-Yuek Robin
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2009, 5 : 553 - 561
  • [3] Efficacy of memantine in moderate to severe Alzheimer's disease
    Wilkinson, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 318 - 318
  • [4] Long-term efficacy and safety benefits from treatment with the NMDA antagonist memantine: results of a 24-week, open-label extension study in moderate to severe Alzheimer's disease
    Moebius, HJ
    Reisberg, B
    Schmitt, F
    Doody, R
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S388 - S389
  • [5] Update of memantine safety in short- and long-term treatment of mild to severe Alzheimer's disease
    Alva, G.
    Farlow, M. R.
    Porsteinsson, A.
    Graham, S. M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 51 - 52
  • [6] Update of memantine safety in 6-month and long-term treatment of mild to severe Alzheimer's disease
    Alva, Gustavo
    FarloW, Martin R.
    Porsteinsson, Anton
    Graham, Stephen M.
    BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 141S - 141S
  • [7] Efficacy and Safety of Long-Term Mirikizumab Treatment in Patients With Moderate to Severe Crohn's Disease
    Sands, Bruce E.
    D'Haens, Geert R.
    Hisamatsu, Tadakazu
    Jairath, Vipul
    Barnes, Edward
    Pellanda, Paola
    Hozak, Rebecca
    Lin, Zhantao
    Yu, Guanglei
    Protic, Marijana
    Owen, Charles C.
    Fischer, Monika
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1040 - S1041
  • [8] Donepezil in the treatment of Alzheimer's disease - Long-term efficacy and safety
    Rocca, P
    Cocuzza, E
    Marchiaro, L
    Bogetto, F
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2002, 26 (02): : 369 - 373
  • [9] Responders to memantine treatment in moderate to severe Alzheimer's disease
    Stöffler, A
    Ferris, SH
    Wirth, Y
    Reisberg, B
    NEUROBIOLOGY OF AGING, 2004, 25 : S212 - S212
  • [10] Tacrin for the treatment of mild to moderate Alzheimer disease: efficacy and safety of long-term therapy
    Steinwachs, KC
    NERVENHEILKUNDE, 1998, 17 (07) : 272 - 277
12345